ProMeris Duo

RSS

Withdrawn

This medicine's authorisation has been withdrawn

metaflumizone / amitraz
MedicineVeterinaryWithdrawn

Dutch is available via eTranslation, the European Commission's machine translation service.

Translate to Dutch | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for ProMeris Duo has been withdrawn at the request of the marketing authorisation holder.

български (BG) (268.89 kB - PDF)

Bekijk

español (ES) (234.19 kB - PDF)

Bekijk

čeština (CS) (263.37 kB - PDF)

Bekijk

dansk (DA) (231.6 kB - PDF)

Bekijk

Deutsch (DE) (237.07 kB - PDF)

Bekijk

eesti (ET) (231.04 kB - PDF)

Bekijk

ελληνικά (EL) (273.19 kB - PDF)

Bekijk

français (FR) (234.85 kB - PDF)

Bekijk

italiano (IT) (230.99 kB - PDF)

Bekijk

latviešu (LV) (271.61 kB - PDF)

Bekijk

lietuvių (LT) (260.01 kB - PDF)

Bekijk

magyar (HU) (258.27 kB - PDF)

Bekijk

Malti (MT) (269.89 kB - PDF)

Bekijk

Nederlands (NL) (232.34 kB - PDF)

Bekijk

polski (PL) (261.12 kB - PDF)

Bekijk

português (PT) (233.54 kB - PDF)

Bekijk

română (RO) (259.96 kB - PDF)

Bekijk

slovenčina (SK) (264.08 kB - PDF)

Bekijk

slovenščina (SL) (250.13 kB - PDF)

Bekijk

suomi (FI) (232.08 kB - PDF)

Bekijk

svenska (SV) (233.25 kB - PDF)

Bekijk

Product information

български (BG) (555.84 kB - PDF)

Bekijk

español (ES) (463.63 kB - PDF)

Bekijk

čeština (CS) (510.99 kB - PDF)

Bekijk

dansk (DA) (459.91 kB - PDF)

Bekijk

Deutsch (DE) (565.04 kB - PDF)

Bekijk

eesti (ET) (467.29 kB - PDF)

Bekijk

ελληνικά (EL) (564.31 kB - PDF)

Bekijk

français (FR) (554.89 kB - PDF)

Bekijk

italiano (IT) (606.2 kB - PDF)

Bekijk

latviešu (LV) (595.88 kB - PDF)

Bekijk

lietuvių (LT) (529.65 kB - PDF)

Bekijk

magyar (HU) (592.54 kB - PDF)

Bekijk

Malti (MT) (547.9 kB - PDF)

Bekijk

Nederlands (NL) (466.67 kB - PDF)

Bekijk

polski (PL) (634.45 kB - PDF)

Bekijk

português (PT) (565.16 kB - PDF)

Bekijk

română (RO) (532.02 kB - PDF)

Bekijk

slovenčina (SK) (543.1 kB - PDF)

Bekijk

slovenščina (SL) (539.48 kB - PDF)

Bekijk

suomi (FI) (477.98 kB - PDF)

Bekijk

svenska (SV) (457.92 kB - PDF)

Bekijk

Íslenska (IS) (462.33 kB - PDF)

Bekijk

norsk (NO) (546.57 kB - PDF)

Bekijk
Latest procedure affecting product information:IB/0011
08/07/2015

български (BG) (197.83 kB - PDF)

Bekijk

español (ES) (145.18 kB - PDF)

Bekijk

čeština (CS) (186.36 kB - PDF)

Bekijk

dansk (DA) (145.68 kB - PDF)

Bekijk

Deutsch (DE) (154.34 kB - PDF)

Bekijk

eesti (ET) (145.19 kB - PDF)

Bekijk

ελληνικά (EL) (198.38 kB - PDF)

Bekijk

français (FR) (145.66 kB - PDF)

Bekijk

italiano (IT) (145.84 kB - PDF)

Bekijk

latviešu (LV) (199.11 kB - PDF)

Bekijk

lietuvių (LT) (184.36 kB - PDF)

Bekijk

magyar (HU) (185.85 kB - PDF)

Bekijk

Nederlands (NL) (145.6 kB - PDF)

Bekijk

polski (PL) (164.96 kB - PDF)

Bekijk

português (PT) (145.14 kB - PDF)

Bekijk

română (RO) (146.57 kB - PDF)

Bekijk

slovenčina (SK) (183.09 kB - PDF)

Bekijk

slovenščina (SL) (162.45 kB - PDF)

Bekijk

suomi (FI) (149.94 kB - PDF)

Bekijk

svenska (SV) (145.54 kB - PDF)

Bekijk

Íslenska (IS) (146.14 kB - PDF)

Bekijk

norsk (NO) (145.55 kB - PDF)

Bekijk

Product details

Name of medicine
ProMeris Duo
Active substance
  • metaflumizone
  • amitraz
International non-proprietary name (INN) or common name
  • metaflumizone
  • amitraz
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QP53AD51

Pharmacotherapeutic group

Ectoparasiticides for topical use, incl. insecticides

Therapeutic indication

For the treatment and prevention of infestations by fleas (Ctenocephalides canis and C. felis), and ticks (Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus, Dermacentor reticulatus and Dermacentor variabilis), and treatment of demodicosis (caused by Demodex spp.) and lice (Trichodectes canis) in dogs.

The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

Authorisation details

EMA product number
EMEA/V/C/000108
Marketing authorisation holder
Pfizer Limited 

Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ
United Kingdom

Marketing authorisation issued
19/12/2006
Revision
7

Assessment history

This page was last updated on

Share this page